IMR Press / CEOG / Volume 33 / Issue 4 / pii/2006065

Clinical and Experimental Obstetrics & Gynecology (CEOG) is published by IMR Press from Volume 47 Issue 1 (2020). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.

Case Report

MRI investigation for neurofibromatosis type 1 lesions during pregnancy - A case report

Show Less
1 1st Department of Obstetrics and Gynecology “Alexandra Maternity Hospital”, University of Athens, Athens (Greece)
2 Radiology Department, University of Patra, Parra (Greece)
3 1st Department of Pediatrics, “Aghia Sophia”, Children’s Hospital, University of Athens, Athens (Greece)
Clin. Exp. Obstet. Gynecol. 2006, 33(4), 246–248;
Published: 10 December 2006
Abstract

Background: Neurofibromatosis type I (NFl) is a genetic disorder of the nervous system that causes tumor growth on the nerves, skin changes and bone deformities, and it is reported to be associated with adverse perinatal outcome in pregnant women. Case: We report a case of MRI investigation of a pregnant woman with a known NFl disease who showed exacerbation of skin lesions during pregnancy. No dangerous lesions that could compromise pregnancy outcome were detected, thus allowing the preg­nancy to continue to term uneventfully. Conclusion: MRI has strong indications for the follow-up of pregnant patients with neurofibromatosis as it can detect lesions that can serve as risk factors for pregnancy complications.

Keywords
MRI
Neurofibromatosis type Ⅰ
Pregnancy
Share
Back to top